# Evaluation of the Tissue Genesis Icellator Cell Isolation System to Treat Erectile Dysfunction

> **NCT03518333** · NA · UNKNOWN · sponsor: **Tissue Genesis** · enrollment: 60 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DEVICE:** Injection of adipose derived cells into penis

## Key facts

- **NCT ID:** NCT03518333
- **Lead sponsor:** Tissue Genesis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03518333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03518333, "Evaluation of the Tissue Genesis Icellator Cell Isolation System to Treat Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03518333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*